Home/Polygon Therapeutics/Tatiana Monseur
TM

Tatiana Monseur

Chief Operating & Financial Officer & Co-founder

Polygon Therapeutics

Therapeutic Areas

Polygon Therapeutics Pipeline

DrugIndicationPhase
PLG-101 (EMOTION Program)Acute Myocardial Infarction (Heart Attack)Pre-clinical